Integra LifeSciences Holdings Corporation

US$13.42As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IARTHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (10.27%)
Div yield —
ROE 1.24%
Medical Devices
Beta (5Y) 1.28
PE TTM 79.91
TSR TTM 11.74%
Mkt cap US$1.044B
ROIC 3.42%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$15
9.78%
48.99%
Hold 1|7|5|9|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.16
0.18
0.17
0.18
12.11%
11.36%
9.62%
13.40%
Revenue$M
111.6
110.6
114.6
115.6
(1.98%)
(2.08%)
0.83%
2.30%
Peers (US$1.044B)
Cap (US$)
PE
1.104B
46.16x
1.094B
—
1.033B
—
1.046B
18.89x
Capital
TTM
5Y
10Y
Leveragex
0.942
(0.011)
(0.011)
EBIT/Intx
0.328
0.306
0.374
Own earn%
(37.45)
(20.02)
(17.25)
Sh yield%
31.91
51.67
52.98
Owners
Insiders/Inst%
0.49
53.61
Short interest%
2.05
SBC / revenue%
5.63
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
0–8
$1 testx
—
Incr. ROIC%
0